Anti-mycobacterial activities of some cationic and anionic calix[4]arene derivatives

Bioorganic and Medicinal Chemistry

Volumn 20, Issue 6, 2012, Pages 2035-2041

  Mourer, Maxime ^a   Massimba Dibama, Hugues ^a   Constant, Patricia ^b,c   Daffé, Mamadou ^b,c   Regnouf De Vains, Jean Bernard ^a  

^a NANCY UNIVERSITÉ   (France)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Ammonium; Anti mycobacterial; Bipyridine; Bithiazole; Calixarene; Guanidinium

Indexed keywords

5,11,17,23 TETRA (SULFONIC ACID) 25,27 BIS(6 METHYLENEOXY 6' METHYL 2,2' BIPYRIDYL) 26,28 DIHYDROXYCALIX[4]ARENE; 5,11,17,23 TETRA [(PHOSPHONO)METHYL] 25,27 BIS(6 METHYLENEOXY 6' METHYL 2,2' BIPYRIDYL) 26,28 DIHYDROXYCALIX[4]ARENE; ANTIMYCOBACTERIAL AGENT; CALIX[4]ARENE DERIVATIVE; CALIXARENE; CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; IC 50; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; STRUCTURE ACTIVITY RELATION;

2,2'-DIPYRIDYL; ANIONS; ANTITUBERCULAR AGENTS; CALIXARENES; GUANIDINE; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PHENOLS; QUATERNARY AMMONIUM COMPOUNDS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84857913903     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2012.01.041     Document Type: Article

References (50)

1. (a) The global plan to stop TB 2011-2015: World Health Organization, Geneva, Switzerland, 2011; http://www.stoptb.org/assets/documents/global/plan/ TB-GlobalPlanToStopTB2011-2015.pdf, and http://www.stoptb.org/assets/documents/ global/plan/stopTB2011-overview-FR.pdf; -(b) 2011/2012 Tuberculosis Global Facts, World Health Organization, Geneva, Switzerland, 2012; http://www.who.int/tb/publications/2011/factsheet-tb-2011.pdf.
2. S.H.E. Kaufmann, G. Hussey, and P.-H. Lambert The Lancet 375 2010 2110
3. M.V.N. de Souza Recent Pat. Anti-Infect. Drug Discovery 1 2006 33
4. J.C. Palomino, D.F. Ramos, and P.A. da Silva Curr. Med. Chem. 1898 2009 16
5. Z. Ma, C. Lienhardt, H. Mcilleron, A.J. Nunn, and X. Wang The Lancet 375 2010 2100
6. J.W. Cornforth, P. D'Arcy Hart, G.A. Nicholls, R.J.W. Rees, and J.A. Stock Br. J. Pharmacol. Chemother. 10 1955 73
7. For example: J.W. Cornforth, P. D'Arcy Hart, R.J.W. Rees, and J.A. Stock Nature London United Kingdom 168 1951 150
8. J.W. Cornforth, E.D. Morgan, K.T. Potts, and R.J.W. Rees Tetrahedron 29 1973 1659
9. For an history of this exciting debate, see: C.D. Gutsche Calixarenes 1989 The Royal Society of Chemistry Cambridge Chapter 1
10. V. Bocchi, D. Foina, A. Pochini, R. Ungaro, and G.D. Andreetti Tetrahedron 38 1982 373
11. For example: R.J.W. Rees Am. Rev. Tuberc. Pulm. Dis. 76 1957 915
12. For example: D.H. Boyd, S.M. Stewart, A.R. Somner, J.W. Crofton, and R.J. Rees Tubercle 40 1959 369
13. For example: P. D'Arcy Hart, J.A. Armstrong, and E. Brodaty Infect. Immun. 64 1996 1491
14. G. Hervé, D.U. Hahn, A.-C. Hervé, K.J. Goodworth, J.A.M. Hill, and H.C. Hailes Org. Biomol. Chem. 1 2003 427
15. M.J. Colston, H.C. Hailes, E. Stavropoulos, A.C. Herve, G. Herve, K.J. Goodworth, A.M. Hill, P. Jenner, P.D. Hart, and R.E. Tascon Infect. Immun. 72 2004 6318
16. F.A. Loiseau, A.M. Hill, and K.K. Hii Tetrahedron 63 2007 9947
17. K.J. Goodworth, A.-C. Hervé, E. Stavropoulos, G. Hervé, I. Casades, A.M. Hill, G.G. Weingarten, R.E. Tascon, M.J. Colston, and H.C. Hailes Tetrahedron 67 2011 373
18. A. DeFatima, S.A. Fernandes, and A.A. Sabino Curr. Drug Discov. Tech. 6 2009 151 and ibid 2009, 6, 306
19. R.V. Rodik, V.I. Boyko, and V.I. Kalchenko Curr. Med. Chem. 16 2009 1630
20. F. Perret, and A.W. Coleman Chem. Commun. 47 2011 7303
21. Yo, T.; Fujiwara, K.; Otsuka, M. JP 10203906, 1998.
22. Harris, S. J. WO Patent 9519974, 1995.
23. A. Casnati, M. Fabbi, N. Pelizzi, A. Pochini, F. Sansone, R. Ungaro, E. Di Modugno, and G. Tarzia Bioorg. Med. Chem. Lett. 6 1996 2699
24. During revision process of the present manuscript: Patel, M. B.; Modi, N. R.; Raval, J. P.; Menon, S. K. Org. Biomol. Chem., doi: 10.1039/c2ob06730g.
25. M. Mourer, N. Psychogios, G. Laumond, A.-M. Aubertin, and J.-B. Regnouf-de-Vains Bioorg. Med. Chem. 18 2010 36
26. M. Leeb Nature 431 2004 892
27. M. Mourer, R.E. Duval, C. Finance, and J.-B. Regnouf-de-Vains Bioorg. Med. Chem. Lett. 16 2006 2960
28. M. Grare, M. Mourer, J.-B. Regnouf-de-Vains, C. Finance, and R.E. Duval Pathol. Biol. 54 2006 470
29. M. Grare, M. Mourer, S. Fontanay, J.-B. Regnouf-de-Vains, C. Finance, and R.E.J. Duval Antimicrob. Chemoth. 60 2007 575
30. M. Grare, E. Dague, M. Mourer, J.-B. Regnouf-de-Vains, C. Finance, J.F.L. Duval, R.E. Duval, and F. Gaboriaud Pathol. Biol. 55 2007 465
31. M. Mourer, H. Massimba Dibama, S. Fontanay, M. Grare, R.E. Duval, C. Finance, and J.-B. Regnouf-de-Vains Bioorg. Med. Chem. 17 2009 5496
32. M. Grare, S. Fontanay, H. Massimba Dibama, M. Mourer, J.-B. Regnouf-de-Vains, C. Finance, and R.E. Duval Pathol. Biol. 58 2010 46
33. M. Grare, H. MassimbaDibama, S. Lafosse, A. Ribon, M. Mourer, S. Fontanay, C. Finance, J.-B. Regnouf-de-Vains, and R.E. Duval Clin. Microbiol. Infect. 16 2010 432
34. L.E.N. Quadri M. Daffé, J.-M. Reyrat, The Mycobacterial Cell Envelope 2008 ASM Press Washington DC 167 184 Chapter 10
35. Regnouf-de-Vains, J.-B.; Lamartine, R.; Choquard, P.; Marcillac, A. WO9749677; 1997.
36. A.W. Coleman, S.G. Bott, S.D. Morley, C.M. Means, K.D. Robinson, H. Zhang, and J.L. Atwood Angew. Chem. 100 1988 1412
37. M. Mourer, and J.-B. Regnouf-de-Vains Tetrahedron Lett. 2006 1895 47
38. P.D. Beer, J.P. Martin, and M.G.B. Drew Tetrahedron 48 1992 9917
39. C. Jaime, J. de Mendoza, P. Prados, P.M. Nieto, and C. Sanchez J. Org. Chem. 56 1991 3372
40. J.O. Magrans, J. de Mendoza, M. Pons, and P. Prados J. Org. Chem. 62 1997 4518
41. N. Psychogios, and J.-B. Regnouf-de-Vains Tetrahedron Lett. 43 2002 7691 and references cited therein
42. F.B. do Nascimento, G. Von Poelhsitz, F.R. Pavan, D.N. Sato, C.Q.F. Leite, H.S. Selistre-de-Araújo, J. Ellena, E.E. Castellano, V.M. Deflon, and A.A. Batista J. Inorg. Biochem. 102 2008 1783
43. M.A.H. de Zwart, H. van der Goot, and H. Timmerman J. Med. Chem. 32 1989 487
44. A.M. Dhople, M.A. Ibanez, and A.A. Dhople Antimicrob. Agents Chemoth. 38 1994 2908
45. A.M. Dhople, A.A. Dhople, and M.A. Ibanez Tuber. Lung Dis. 76 1995 136
46. D.K. Saha, S. Padhye, C.E. Anson, and A.K. Powell Transition Met. Chem. 28 2003 579
47. Y. Zhang, B. Heym, B. Allen, D. Young, and S. Cole Nature 358 1992 591
48. P. De, G. Koumba Yoya, P. Constant, F. Bedos-Belval, H. Duran, N. Saffon, M. Daffé, and M. Baltas J. Med. Chem. 54 2011 1449
49. M.B. Hansen, S.E. Nielsen, and K. Berg J. Immunol. Methods 119 1989 203
50. R. Gomez-Flores, S. Gupta, R. Tamez-Guerra, and R.T. Mehta J. Clin. Microbiol. 1995 1842 33